CLINICAL_TRIALS
trial_result
· 2014-02-28
Clinical Trial Update: Dose-response Study of OPC-12759 Ophthalmic Suspension [Phase 2]
Summary
Phase 2 dose-response study of OPC-12759 ophthalmic suspension for dry eye disease. The study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28